MZL genes

Tier 1, high-confidence MZL genes

Gene Status First MZL study Other lists
ACTB MZL Tier 1 DLBCL, FL, PMBL
ARID1A MZL Tier 1 Rossi et al BL, DLBCL, FL, PMBL
ATM MZL Tier 1 Braggio et al DLBCL, MCL
BCL10 MZL Tier 1 Spina et al DLBCL, FL
BCL7A MZL Tier 1 BL, DLBCL, FL, PMBL
BIRC3 MZL Tier 1 Rossi et al DLBCL, PMBL, MCL
BRAF MZL Tier 1 BL, DLBCL
BTG1 MZL Tier 1 BL, DLBCL, FL, PMBL
CARD11 MZL Tier 1 Yan et al BL, DLBCL, FL, MCL
CCND3 MZL Tier 1 Jallades et al BL, DLBCL, FL, PMBL
CXCR4 MZL Tier 1 BL, DLBCL, FL
DTX1 MZL Tier 1 Rossi et al BL, DLBCL, PMBL
EP300 MZL Tier 1 Rossi et al DLBCL, FL
EZH2 MZL Tier 1 BL, DLBCL, FL, PMBL
FAS MZL Tier 1 Spina et al DLBCL, FL, PMBL
FAT1 MZL Tier 1 Spina et al PMBL
FOXO1 MZL Tier 1 BL, DLBCL, FL, PMBL
H1-4 MZL Tier 1
H1-5 MZL Tier 1
ID3 MZL Tier 1 Spina et al BL, DLBCL
KLF2 MZL Tier 1 Jallades et al DLBCL, FL, PMBL
KLHL6 MZL Tier 1 Ganapathi et al DLBCL, FL
KMT2D MZL Tier 1 Rossi et al BL, DLBCL, FL, PMBL, MCL
MAP3K14 MZL Tier 1 Rossi et al PMBL
MPEG1 MZL Tier 1 DLBCL
MYD88 MZL Tier 1 Yan et al DLBCL, FL
NCOR2 MZL Tier 1 Spina et al BL, PMBL
NOL9 MZL Tier 1 Spina et al DLBCL
NOTCH1 MZL Tier 1 Rossi et al BL, DLBCL, MCL
NOTCH2 MZL Tier 1 Rossi et al DLBCL, MCL
PCLO MZL Tier 1 DLBCL, PMBL
POU2AF1 MZL Tier 1 DLBCL, FL
PTPRD MZL Tier 1 Spina et al DLBCL, FL, PMBL
SIN3A MZL Tier 1 Rossi et al BL, DLBCL, PMBL
SOCS1 MZL Tier 1 DLBCL, FL, PMBL
SPEN MZL Tier 1 Rossi et al DLBCL, PMBL
STAT6 MZL Tier 1 DLBCL, FL, PMBL
TBL1XR1 MZL Tier 1 Rossi et al BL, DLBCL, FL, PMBL
TNFAIP3 MZL Tier 1 Rossi et al DLBCL, FL, PMBL
TNFRSF14 MZL Tier 1 Spina et al BL, DLBCL, FL
TP53 MZL Tier 1 Rossi et al BL, DLBCL, FL, PMBL, MCL
TRAF3 MZL Tier 1 Rossi et al DLBCL, PMBL

Tier 2, low-confidence MZL genes

Gene Status First MZL study Other lists
ABCA13 MZL Tier 2 Spina et al PMBL
ACTG1 MZL Tier 2 Spina et al DLBCL, FL, PMBL
ADD2 MZL Tier 2 Spina et al
AMN MZL Tier 2 Spina et al
AMOTL1 MZL Tier 2 Parry et al
AOC2 MZL Tier 2 Spina et al
ARHGAP20 MZL Tier 2 Jallades et al
ARHGEF15 MZL Tier 2 Jallades et al
ARHGEF17 MZL Tier 2 Jallades et al
BCOR MZL Tier 2 Jallades et al MCL
C6orf103 MZL Tier 2 Spina et al
CBFA2T3 MZL Tier 2 Parry et al
CD79A MZL Tier 2 Rossi et al BL
CD9B MZL Tier 2 Vandenbrand et al
CDC42BPB MZL Tier 2 Spina et al FL
CDKN2A MZL Tier 2 Spina et al BL, DLBCL, PMBL
CLGN MZL Tier 2 Spina et al
CNBP MZL Tier 2 Spina et al
CNKSR2 MZL Tier 2 Spina et al
CREBBP MZL Tier 2 Parry et al BL, DLBCL, FL, PMBL
DNAH5 MZL Tier 2 Jallades et al DLBCL
DNAH7 MZL Tier 2 Jallades et al
DNAI1 MZL Tier 2 Jallades et al
DOCK6 MZL Tier 2 Jallades et al
DSP MZL Tier 2 DLBCL
DTNB MZL Tier 2
DTX3L MZL Tier 2 Jallades et al
EGR1 MZL Tier 2 Rossi et al FL, PMBL
EGR2 MZL Tier 2 Rossi et al
EZH1 MZL Tier 2 Jallades et al
FAT4 MZL Tier 2 Parry et al DLBCL, PMBL, MCL
FBXO11 MZL Tier 2 Parry et al BL, DLBCL
GPR98 MZL Tier 2 Spina et al
GPS2 MZL Tier 2 Rossi et al
HIST1H1D MZL Tier 2 Jallades et al DLBCL, FL, PMBL
HIST1H2AD MZL Tier 2 Jallades et al
HIST1H2AG MZL Tier 2 Rossi et al BL, DLBCL, FL
HIST1H2BK MZL Tier 2 Rossi et al BL, DLBCL
HIST4H4 MZL Tier 2 Jallades et al
HRAS MZL Tier 2 Jallades et al DLBCL
IKBKB MZL Tier 2 Rossi et al DLBCL, PMBL
KAT6A MZL Tier 2 Jallades et al
KDM6A MZL Tier 2 Jallades et al
KIF26A MZL Tier 2 Jallades et al
LRP1B MZL Tier 2 Spina et al DLBCL
MCRS1 MZL Tier 2 Rossi et al
MGA MZL Tier 2 Jallades et al DLBCL
MSL2 MZL Tier 2 Rossi et al
MYC MZL Tier 2 Jallades et al BL, DLBCL, FL, PMBL
MYLK MZL Tier 2 Jallades et al
NCOA6 MZL Tier 2 Jallades et al
NRAS MZL Tier 2 Jallades et al
PACRG MZL Tier 2 Spina et al
PARK2 MZL Tier 2 Spina et al
PLA2G4D MZL Tier 2 Parry et al
PLXNB3 MZL Tier 2 Spina et al MCL
RAF1 MZL Tier 2 Jallades et al DLBCL
RAPGEF2 MZL Tier 2 DLBCL
RCOR1 MZL Tier 2 Spina et al
RFTN1 MZL Tier 2 DLBCL, PMBL
ROCK1 MZL Tier 2 Jallades et al
RPL1L MZL Tier 2 Spina et al
SAMD5 MZL Tier 2 Spina et al
SCG3 MZL Tier 2 Spina et al
STXBP5 MZL Tier 2 Spina et al
SWAP70 MZL Tier 2 Rossi et al
TAF1 MZL Tier 2 Spina et al DLBCL
TBK1 MZL Tier 2 Jallades et al
TCTN2 MZL Tier 2 Spina et al
TNIP2 MZL Tier 2 Vandenbrand et al
TRRAP MZL Tier 2 Rossi et al DLBCL
USH2A MZL Tier 2 Parry et al
WAC MZL Tier 2 Rossi et al DLBCL
WNK1 MZL Tier 2 Jallades et al BL, DLBCL
Gene Summary First MZL study Other entities QC result
ABCA13 Tier 2 GE1 Spina et al 2
ACTG1 Tier 2 GE1, aSHM Spina et al 35
ADD2 Tier 2 GE1 Spina et al
AMN Tier 2 GE1 Spina et al
AMOTL1 Tier 2 GE6 Parry et al
AOC2 Tier 2 GE1 Spina et al
ARHGAP20 Tier 2 GE7 Jallades et al
ARHGEF15 Tier 2 GE7 Jallades et al
ARHGEF17 Tier 2 GE7 Jallades et al
BCOR Tier 2 GE7 Jallades et al 8
C6orf103 Tier 2 GE1 Spina et al
CBFA2T3 Tier 2 GE6 Parry et al
CD79A Tier 2 GE9 Rossi et al 10
CD9B Tier 2 GE11 Vandenbrand et al
CDC42BPB Tier 2 GE1 Spina et al 5
CDKN2A Tier 2 GE1, FE12 Spina et al 13,14
CLGN Tier 2 GE1 Spina et al
CNBP Tier 2 GE1 Spina et al
CNKSR2 Tier 2 GE1 Spina et al
CREBBP Tier 2 GE6, FE15 Parry et al 1517
DNAH5 Tier 2 GE7 Jallades et al 14
DNAH7 Tier 2 GE7 Jallades et al
DNAI1 Tier 2 GE7 Jallades et al
DOCK6 Tier 2 GE7 Jallades et al
DSP Tier 2 GE 18
DTNB Tier 2 GE
DTX3L Tier 2 GE7 Jallades et al
EGR1 Tier 2 GE9 Rossi et al 19,20
EGR2 Tier 2 GE9 Rossi et al
EZH1 Tier 2 GE7 Jallades et al
FAT4 Tier 2 GE6 Parry et al 14,21
FBXO11 Tier 2 GE6, FE22 Parry et al 23,24
GPR98 Tier 2 GE1 Spina et al
GPS2 Tier 2 GE9 Rossi et al
HIST1H1D Tier 2 GE7, aSHM Jallades et al 14,19
HIST1H2AD Tier 2 GE7 Jallades et al
HIST1H2AG Tier 2 GE9 Rossi et al 14,19,25
HIST1H2BK Tier 2 GE9, aSHM Rossi et al 18,25
HIST4H4 Tier 2 GE7 Jallades et al
HRAS Tier 2 GE7 Jallades et al 26
IKBKB Tier 2 GE27 Rossi et al 26,28
KAT6A Tier 2 GE7 Jallades et al
KDM6A Tier 2 GE7 Jallades et al
KIF26A Tier 2 GE7 Jallades et al
LRP1B Tier 2 GE1 Spina et al 18
MCRS1 Tier 2 GE9 Rossi et al
MGA Tier 2 GE7, FE29 Jallades et al 26
MSL2 Tier 2 GE9 Rossi et al
MYC Tier 2 GE7, FE30, aSHM Jallades et al 16,31,32
MYLK Tier 2 GE7 Jallades et al
NCOA6 Tier 2 GE7 Jallades et al
NRAS Tier 2 GE7 Jallades et al
PACRG Tier 2 GE1 Spina et al
PARK2 Tier 2 GE1 Spina et al
PLA2G4D Tier 2 GE6 Parry et al
PLXNB3 Tier 2 GE1 Spina et al 21
RAF1 Tier 2 GE7 Jallades et al 4
RAPGEF2 Tier 2 GE 18
RCOR1 Tier 2 GE1 Spina et al
RFTN1 Tier 2 GE, aSHM 16,23
ROCK1 Tier 2 GE7 Jallades et al
RPL1L Tier 2 GE1 Spina et al
SAMD5 Tier 2 GE1 Spina et al
SCG3 Tier 2 GE1 Spina et al
STXBP5 Tier 2 GE1 Spina et al
SWAP70 Tier 2 GE9 Rossi et al
TAF1 Tier 2 GE1 Spina et al 14
TBK1 Tier 2 GE7 Jallades et al
TCTN2 Tier 2 GE1 Spina et al
TNIP2 Tier 2 GE11 Vandenbrand et al
TRRAP Tier 2 GE9 Rossi et al 18
USH2A Tier 2 GE6 Parry et al
WAC Tier 2 GE9 Rossi et al 26
WNK1 Tier 2 GE7 Jallades et al 5,33

Tier 3, retired MZL genes

0 total

Gene Summary First MZL study Other entities QC result

References

1.
Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B, Inghirami G, Bertoni F, Foà R, Rabadan R, Gaidano G, Rossi D. The genetics of nodal marginal zone lymphoma. Blood. 2016 Sep 8;128(10):1362–1373. PMCID: PMC5016706
2.
Sarkozy C, Hung SS, Chavez EA, Duns G, Takata K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW, Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A, Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW, Traverse-Glehen A, Steidl C. Mutational landscape of gray zone lymphoma. Blood. 2021 Apr 1;137(13):1765–1776.
3.
Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia. 2020 Jan;34(1):151–166.
4.
Fan Z, Pei R, Sha K, Chen L, Wang T, Lu Y. Comprehensive characterization of driver genes in diffuse large B cell lymphoma. Oncol Lett. 2020 Jul;20(1):382–390. PMCID: PMC7285964
5.
Hübschmann D, Kleinheinz K, Wagener R, Bernhart SH, López C, Toprak UH, Sungalee S, Ishaque N, Kretzmer H, Kreuz M, Waszak SM, Paramasivam N, Ammerpohl O, Aukema SM, Beekman R, Bergmann AK, Bieg M, Binder H, Borkhardt A, Borst C, Brors B, Bruns P, Carrillo de Santa Pau E, Claviez A, Doose G, Haake A, Karsch D, Haas S, Hansmann ML, Hoell JI, Hovestadt V, Huang B, Hummel M, Jäger-Schmidt C, Kerssemakers JNA, Korbel JO, Kube D, Lawerenz C, Lenze D, Martens JHA, Ott G, Radlwimmer B, Reisinger E, Richter J, Rico D, Rosenstiel P, Rosenwald A, Schillhabel M, Stilgenbauer S, Stadler PF, Martín-Subero JI, Szczepanowski M, Warsow G, Weniger MA, Zapatka M, Valencia A, Stunnenberg HG, Lichter P, Möller P, Loeffler M, Eils R, Klapper W, Hoffmann S, Trümper L, ICGC MMML-Seq consortium, ICGC DE-Mining consortium, BLUEPRINT consortium, Küppers R, Schlesner M, Siebert R. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021 Jul;35(7):2002–2016. PMCID: PMC8257491
6.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S, Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier DG, Strefford JC. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PLoS One. 2013;8(12):e83244. PMCID: PMC3862727
7.
Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 2017 Oct;102(10):1758–1766. PMCID: PMC5622860
8.
Nadeu F, Martín-García D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggrós M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera‐Cortada I, Siebert R, Colomer D, Torrents D, Giné E, López-Guillermo A, Küppers R, Martín-Subero J, Puente X, Beà S, Campo E. Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020;
9.
Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R, Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G. The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012 Aug 27;209(9):1537–1551. PMCID: PMC3428941
10.
Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, Gökbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022 Jul 6;13(1):3881. PMCID: PMC9259584
11.
van den Brand M, Rijntjes J, Hebeda KM, Menting L, Bregitha CV, Stevens WBC, van der Velden WJFM, Tops BBJ, van Krieken JHJM, Groenen PJTA. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. Histopathology. 2017 Jan;70(2):174–184.
12.
Kannengiesser C, Brookes S, del Arroyo AG, Pham D, Bombled J, Barrois M, Mauffret O, Avril MFM, Chompret A, Lenoir GM, Sarasin A, French Hereditary Melanoma Study Group, Peters G, Bressac-de Paillerets B. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. Hum Mutat. 2009 Apr;30(4):564–574.
13.
Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019;133(12):1313–1324. PMCID: PMC6428665
14.
Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992
15.
Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011 Mar 10;471(7337):189–195. PMCID: PMC3271441
16.
Duns G, Viganò E, Ennishi D, Sarkozy C, Hung SS, Chavez E, Takata K, Rushton C, Jiang A, Ben-Neriah S, Woolcock BW, Slack GW, Hsi ED, Craig JW, Hilton LK, Shah SP, Farinha P, Mottok A, Gascoyne RD, Morin RD, Savage KJ, Scott DW, Steidl C. Characterization of DLBCL with a PMBL gene expression signature. Blood. 2021 Jul 15;138(2):136–148.
17.
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
18.
Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:1398–1403. PMCID: PMC3557051
19.
Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 2017 Jan 26;129(4):473–483. PMCID: PMC5270390
20.
Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E, Roshal M. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2015 Feb 12;125(7):1061–1072.
21.
Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood. 2014 May 8;123(19):2988–2996.
22.
Duan S, Cermak L, Pagan JK, Rossi M, Martinengo C, di Celle PF, Chapuy B, Shipp M, Chiarle R, Pagano M. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature. 2011 Nov;
23.
Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B, Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001. PMCID: PMC6167379
24.
Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Möller P, MacLeod RAF, Pott C, Schreiber S, Trümper L, Loeffler M, Stadler PF, Lichter P, Eils R, Küppers R, Hummel M, Klapper W, Rosenstiel P, Rosenwald A, Brors B, Siebert R, ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012 Dec;44(12):1316–1320.
25.
Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
26.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017 Oct;171(2):481–494.e15. PMCID: PMC5659841
27.
Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M, Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C, Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F, Dalla-Favera R, Pasqualucci L, Gaidano G. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. Blood. 2011 Nov 3;118(18):4930–4934.
28.
Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, Kamburov A, Wood TR, Cader FZ, Ducar MD, Thorner AR, Nag A, Heubeck AT, Buonopane MJ, Redd RA, Bojarczuk K, Lawton LN, Armand P, Rodig SJ, Fromm JR, Getz G, Shipp MA. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019 Dec 10;3(23):4065–4080. PMCID: PMC6963251
29.
De Paoli L, Cerri M, Monti S, Rasi S, Spina V, Bruscaggin A, Greco M, Ciardullo C, Famà R, Cresta S, Maffei R, Ladetto M, Martini M, Laurenti L, Forconi F, Marasca R, Larocca LM, Bertoni F, Gaidano G, Rossi D. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Leuk Lymphoma. 2013 May;54(5):1087–1090.
30.
Freie B, Carroll PA, Varnum-Finney BJ, Ramsey EL, Ramani V, Bernstein I, Eisenman RN. A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies. Genes Dev. 2024 Apr 17;38(5-6):253–272. PMCID: PMC11065175
31.
Johnston JM, Carroll WL. C-myc hypermutation in Burkitt’s lymphoma. Leuk Lymphoma. 1992 Dec;8(6):431–439.
32.
Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Küppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001 Jul 19;412(6844):341–346.
33.
Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 Feb 23;141(8):904–916. PMCID: PMC10023728